Cannabidiol (CBD) is being hailed as a super-food and health supplement with the potential to treat everything from acne to arthritis. Could it work for alcoholism as well?
Recently, experts have been studying the effects of CBD in heavy drug users. Typically, when people who use heavy drugs such as meth or crack cocaine, attempts to stop using the substance result in some pretty severe withdrawal symptoms. It is these withdrawal symptoms that often cause heavy drug users to remain trapped in the cycle of addition. The mental and physical discomfort of withdrawal are too much to bear.
Clinical studies are pointing towards CBD once again; only this time it is being observed as being a potential deterrent for substance seeking behavior specifically as it relates to alcoholism.
While this theory is still being studied, science is definitely there to back these claims. When our brains become dependent on a substance such as alcohol in order to function, we crave a constant supply of that substance in order to feel right. This isn’t usually an issue for people who go out on the weekends, or have a glass of wine with dinner.
It is the people who drink every day that are likely to see slight withdrawal symptoms when they try to go for a day without alcohol. These withdrawal symptoms will only get worse the higher the persons’ alcohol dependence becomes. The reason for this is that when people become dependent on alcohol, their tolerance often goes up. Rather than getting a buzz from one or two drinks, alcoholics will graduate to higher and higher amounts of alcohol in order to feel the same effects.
A few studies have shown that there is a direct correlation between alcohol abuse and reduced function of CB1 receptors within the endocannabinoid system. It is hoped that CBD will not only provide a more positive experience or habit for those addicted to alcohol but also offer some relief from cravings as well as repair CB1 receptors functionality over time.
Encouragingly, this area of study is ongoing and more information will continue to be available as researchers press forward.